Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Moon Jin Kim, Sung Min Kim, Hyun Ae Jung, Jung Yong Hong, Won Jin Chang, Moon Ki Choi, Hye Sook Kim, Jong-Mu Sun, Keunchil Park, Myung-Ju Ahn
Korean J Intern Med. 2019;34(5):1107-1115. Published online 2018 Jun 20 DOI: https://doi.org/10.3904/kjim.2017.234
Citations to this article as recorded by 
Incidence and Risk Factors of Chemotherapy-Induced Hepatotoxicity: A Cross-Sectional Study
Sebisaalu Joel, Sarad Bukke, Bharath Mamilla Mugaiahgari, Julius Kyomya, Kato Idrine, Nimusiima Godwin, Patrick Muasya, Amina Abdi, Kabera Makuza, John Tumwebaza, Bayapa Reddy Narapureddy, Narayana Goruntla, Daniel Mwandah, Alrazi Shogar, Safa Abdalla, Jo
Cancer Management and Research.2026; Volume 18: 1. CrossRef
A circadian rhythm-related lncRNA signature correlates with prognosis and tumor immune microenvironment in head and neck squamous cell carcinoma
Hongyu Zheng, Qiuyue Li, Kai Yang
Discover Oncology.2024;[Epub] CrossRef
Cisplatin/docetaxel
Reactions Weekly.2019; 1779(1): 69. CrossRef